RecruitingNot applicableNCT06268990

FMT in Obesity: RYGB vs. LEAN vs. Autologous FMT

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Wiebke Kristin Fenske
Principal Investigator
Wiebke K. Fenske, Prof. Dr.
University Hospital Bergmannsheil Bochum
Intervention
Fecal microbiota transplantation(procedure)
Enrollment
30 target
Eligibility
18-60 years · All sexes
Timeline
20232025

Study locations (1)

Collaborators

Medical University of Graz

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06268990 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials